You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Geisinger Health was facing a potential loss of more than $20 million due to the reimbursement impact on lab testing driven by the Protecting Access to Medicare Act (PAMA). Find out how the integrated health system turned this major challenge into an opportunity by consolidating lab services, optimizing staffing resources and ultimately improving access to care.
Together, Roche and Geisinger Health:
Found processes that could be made more efficient
Evaluated testing needs and cost impacts
Identified areas of excess capacity
Reduced the number of non-essential tests
Related Stories
VIDEO
Expanding hospital outreach serves the community — and the bottom line
See how one hospital increased laboratory annual billables and reduced costs, enabling it to expand services for the community.
